PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1401783
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1401783
Cell Culture Market size was valued at USD 16,480 Million in 2022, expanding at a CAGR of 11.5% from 2023 to 2030.
Cell Culture Market- Market Dynamics
Cell culture is the process of cultivating cells under strictly controlled circumstances away from their natural habitat. The application of cell culture techniques is crucial in granting scientists novel insights into the biology of cells and the effectiveness of pharmaceuticals. Moreover, cell culture products are designed to reduce the possibility of contamination and preserve the viability of cell culture samples.
The rapid adoption of cell culture techniques propelling the growth of the market
The rapid use of cell culture techniques to create safe platforms for the manufacturing of viral vaccines and the growing demand for enhanced therapeutic pharmaceuticals worldwide are contributing to the growth of the cell culture market. Furthermore, aseptic techniques and proper cell culture practices must be used to ensure cell culture safety, encourage the production of repeatable scientific data, and make it easier to compare results obtained in different laboratories. Moreover, new three-dimensional cell culture methods, the expanding requirement for biopharmaceutical development, and the manufacturing of vaccines are anticipated to propel market expansion during the projected year.
Cell Culture Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.5% over the forecast period (2023-2030)
Based on product type segmentation, the consumables segment accounted for the largest market share in 2022
Based on application segmentation, biopharmaceutical production is expected to capture a significant market share over the anticipated timeframe
Based on region, North America is expected to dominate the market during the forecast period
The Global Cell Culture Market is segmented based on Product Type, Application, and Region.
Based on the product type, the cell culture industry is categorized into consumables and instruments. The consumables segment accounted for the largest market share in 2022 and is expected to continue the same pattern during the forecast period. The segment expansion is ascribed to the ongoing demand and consumable purchases. The segment's growth is also being driven by biotechnology and biopharmaceutical companies investing more in research and development to create complex biologics like vaccines and monoclonal antibodies.
Based on the application, the cell culture market is bifurcated into Cell & Gene Therapy, Diagnostics, Tissue Culture & Engineering, Drug Development, Toxicity Testing, Biopharmaceutical Production and Others. Biopharmaceutical production is expected to capture a significant market share over the anticipated timeframe. The utilization of mammalian cell lines, such as the Chinese hamster ovary, in the manufacturing of biopharmaceuticals and the rising demand for alternative therapies are expected to lead to an expansion of the biopharmaceutical uses of cell culture techniques. Furthermore, the potential of the biopharmaceutical sector has expanded because of recent advancements in grafting techniques and novel options in tailored therapy.
Cell Culture Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. The region's well-established biotech and pharmaceutical industries as well as the extensively used, cutting-edge technologies in the U.S. are credited for a significant portion of the share. Furthermore, a sizable market exists for cell culture technologies as a result of the intensive research projects on cell treatment that several institutions have undertaken. The rising incidence of infectious & chronic diseases in this area increases the demand for cell culturing methods in research & clinical applications.
The increasing demand for monoclonal antibodies, the growing funding for studies based on cells, the growing preference for single-use techniques, the growing knowledge of the benefits of cell-based vaccines, and the increased focus on personalized medicine are all contributing to the significant development of the global cell culture market. Furthermore, the growing prevalence of diseases like cancer necessitates precision medicine, which in turn fuels the market's expansion by raising demand for cell culture items and supplies for their advancement. The launch of products by the market players is also expected to drive the growth of the market.
In November 2023, Lonza declared the opening of its new GS Effex® cell line to facilitate the production of more potent therapeutic antibodies. The GS Effex® cell line was created in response to urgent market demands brought on by the move toward more advanced therapeutic antibodies. GS Effex®, which is derived from Lonza's top-performing GS Xceed® cell line, integrates well with Lonza platforms. When coupled with robust cell growth and the capacity to generate potent therapeutic antibodies, this unique cell line offers a solution for therapeutic development spanning from early-stage research to commercial manufacture.
The scope of this report covers the market by its major segments, which include as follows: